Skip to main content

DIADEMA PARTNERS LP

Position in RVMD — Revolution Medicines, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,072,747
+$18,207,945 QoQ
Shares Held
139,218
+72.1% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
9.85%
of 13F equity value
Holder Rank
#122
of 687 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$12,204,875
PutShares
125,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names. RVMD ranks #1 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
This page
139,218 $26,072,747

All Filings in RVMD

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,072,747 139,218
2026-03-31 $7,864,802 80,872
2026-03-31 $12,204,875 125,500
2025-12-31 $2,948,643 37,020
2025-09-30 $2,758,989 59,079
2025-06-30 $2,909,316 79,079
2025-06-30 $7,358,000 200,000